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CMA as the first-tier test for the identification of pathogenic CNVs in chromosome 9 pericentric regions and its challenge.
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Chromosomal microarray analysis (CMA) has been recommended as the first-tier test for the postnatal evaluation of individuals with intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies since 2010 \[[@CR1], [@CR2]\], and was later confirmed by other group \[[@CR3]\]. This practice has become a standard for the large reference laboratories in U.S.A after the American College of Medical Genetics (ACMG) published the professional guidelines \[[@CR4]\]. In these laboratories, CMA has largely replaced fluorescence in situ hybridization (FISH) analysis for the identification of pathogenic copy number variants (CNVs) across the whole genome.

Chromosome 9 pericentric regions have been known to contain a very complex genomic structure because of the presence of a huge amount of heterochromatin and large tracks of segmentally duplicated euchromatin \[[@CR5], [@CR6]\]. The segmentally duplicated sequences predispose and mediate the generation of deletion, duplication, insertion, triplication and amplification variants within the pericentric regions of chromosome 9 \[[@CR5], [@CR7]\]. In a cohort of 334 carriers studied by using FISH analysis with different sets of labeled bacterial artificial chromosome (BAC) probes (BAC-FISH), 17 different types of heterochromatic variants of chromosome 9 have been identified \[[@CR6]\], with pericentric inversions being the most frequent variant (50 %) followed by 9qh-variants (24 %) and 9ph-variants (11 %). Additionally, four different types of euchromatic variants have been detected: (1) 9p12 amplification variant \[[@CR8], [@CR9]\], (2) 9q12 insertion variant \[[@CR5]\], (3) 9q21 deletion variant \[[@CR5]\], and (4) 9q21 amplification variant \[[@CR7]\]. Because of the presence of repetitive sequences, chromosomal microarray analysis (CMA) was not recommended to be utilized since it may lead to false positive results \[[@CR6], [@CR7]\].

For this reason, we retrospectively reviewed our postnatal database to search interesting cases with CNVs in chromosome 9. High-resolution CMA was either used as the first-tier test or simultaneously ordered with G-banding analysis. For G-banding, peripheral blood was cultured for 72 h in RPMI-1640 medium. Metaphase chromosomes were analyzed using standard G-banding techniques. CMA was performed using genomic DNA extracted from uncultured whole blood on the oligo-SNP array (CytoScan HD^®^, Affymetrix). Hybridization, data extraction and analysis were performed as per manufacturer's protocols. The Affymetrix^®^ Chromosome Analysis Suite (ChAS) Software version 2.0 was used for data analysis, review and reporting. For chromosome 9, the probes from CytoScan HD^®^ covered the following genomic regions: 9p (chr9:192,129--40,784,142, 43,400,082--44,900,526) and 9q (chr9:66,837,485--141,025,328). Thresholds are set at \>200 kb for gains, \>50 kb for losses for genome-wide region, and at \>100 kb for gains, \>20 kb for losses for cytogenetic relevant regions. Genomic coordinates are based upon genome build 37/hg19 (2009).

Patient 1 was a newborn girl who was referred to rule out a chromosomal anomaly. Using G-banding, it was initially reported as a common chromosome 9 normal pericentric inversion variant, 46,XX,inv(9)(p13q21.11), with a morphology similar to inv(9)(var2) in the previous report \[[@CR6]\]. The second reviewer thought it was a large pericentric inversion, 46,XX,inv(9)(p13q32) since the band 9q31 was missing (Fig. [1a](#Fig1){ref-type="fig"}, arrow) and instead inverted to 9p13 region (Fig. [1a](#Fig1){ref-type="fig"}, arrow head), and considered that it was not a variant. Further characterization of this large pericentric inversion by concurrent high-resolution CMA revealed the presence of an interstitial deletion of 14 Mb at 9q22.3--q32 (chr9:104,382,544--118,273,644; hg19; Fig. [1b](#Fig1){ref-type="fig"}; the genes involved were listed in the Additional file [1](#MOESM1){ref-type="media"}: Table S1). The revised karyotype was 46,XX,del(9)(q22.3q32)inv(9)(p13q21.11). It was concluded that two chromosomal rearrangements have occurred to the same chromosome 9: a polymorphic pericentric inversion and an interstitial deletion of 9q22.3--q32. It is actually very difficult to distinguish between the deletion of 9q22--q32 and 9q32--q34 without using molecular cytogenetic methods \[[@CR10], [@CR11]\]. Usually the patients with interstitial deletions involving 9q22 had a loss of the *PTCH1* gene (chr9: 98,205,265--98,279,247), and thus revealed typical features of Gorlin syndrome \[[@CR12]--[@CR14]\]. However, since the deletion in this patient was distal to the *PTCH1* gene, this newborn girl did not have Gorlin syndrome.Fig. 1**a** G-banding analysis of patient 1 revealed a pericentric inversion of chromosome 9; the missing band 9q31 (*arrow*) was initially considered to be inverted to 9p13 region (*arrow head*); **b** CMA identified a pathogenic interstitial deletion of 14 Mb at 9q22.3-q32 (chr9:104,382,544--118,273,644; hg19); **c** G-banding analysis of patient 2 revealed an extra band at 9qh; **d** CMA identified a pathogenic gain of 6.3 Mb from 9q21.33--q22.31 (chr9:90,118,500--96,395,801); **e** G-banding analysis of patient 3 revealed an extra band at the 9q22.1 region; **f** CMA identified a 10.4 Mb pathogenic gain from 9q21.31--q22.2 (chr9:82,745,056--93,173,691); **g** G-banding analysis of patient 4 revealed an extra band at 9q12 region with a morphology similar to that of patient 2; **h** CMA did not reveal copy number changes, which ruled out the presence of pathogenic variants

Patient 2 was a 2-year-old girl with developmental delay, lack of coordination, mixed receptive expressive language disorder and convulsion. It was initially considered as a chromosome 9 euchromatic variant with an extra G-dark band within the proximal 9q heterochromatin region or it could be an insertion or duplication from 9q13--q21.1 (Fig. [1c](#Fig1){ref-type="fig"}, arrow). The C-banding was negative. This type of euchromatic variant has been reported in several cases \[[@CR5], [@CR15], [@CR16]\] and classified as one of the four major categories of euchromatic variant \[[@CR7]\]. The high-resolution CAM that was simultaneously performed, however, showed a genomic gain of 6.3 Mb from 9q21.33--q22.31 (chr9:90,118,500--96,395,801; hg19; Fig. [1d](#Fig1){ref-type="fig"}; genes involved listed in the Additional file [1](#MOESM1){ref-type="media"}: Table S1). This case was an excellent example of how CMA analysis showed that an extra G-dark band in proximal 9q was a pathogenic duplication of proximal 9q rather than a euchromatic variant. This gain did not include the *PTCH1* gene (located at chr9: 98,205,265--98,279,247) and, thus the phenotype was different from the previously reported familial cases with 9q22.3 microduplication spanning *PTCH1* \[[@CR17]\], and without microcephaly or holoprosencephaly that were often seen in patients with gain of *PTCH1* \[[@CR18]\].

Patient 3 was a 24-year-old woman referred to rule out a chromosomal disorder with reported family history of a chromosome 9 abnormality. G-banding analysis considered it was an insertion of an extra band to the 9q22 region (Fig. [1e](#Fig1){ref-type="fig"}). CMA revealed it was a duplication of 10.4 Mb from 9q21.31-q22.2 (chr9:82,745,056--93,173,691; Fig. [1f](#Fig1){ref-type="fig"}; genes involved listed in the Additional file [1](#MOESM1){ref-type="media"}: Table S1). Duplication of 9q21.2--q22.3 was reported in a 2-year-old female with growth and motor retardation and in her aunt without apparent phenotypic anomalies \[[@CR19]\], and a more distal duplication of 9q22.31--q22.32 was associated with congenital diaphragmatic hernia \[[@CR20]\]. Our patient was not known to have these anomalies.

Patient 4 was a 10-year-old boy with failure to thrive and cognitive deficits. G-banding analysis revealed an extra band at 9q12 region (Fig. [1g](#Fig1){ref-type="fig"}), and C-banding was positive (Additional file [2](#MOESM2){ref-type="media"}: Figure S1). CMA did not reveal copy number variants (Fig. [1h](#Fig1){ref-type="fig"}) since the probes from the CMA apparently did not cover the repetitive sequences. The G-positive and C-positive extra band in this case was concluded as a rare heterochromatic variant \[[@CR6]\], instead of a G-positive and C-negative euchromatic variant \[[@CR7]\].

The four cases described here demonstrate how CMA characterize the chromosome 9 pericentric regions along with G-banding and/or C-banding without access to BAC-FISH analysis. Patient 1 was a very rare case with the presence of an interstitial deletion which coexisted with a polymorphic pericentric inversion. Patient 2 was an excellent example of how CMA differentiated a pathogenic gain from a heterochromatic variant as observed in patient 4. In patient 3, CMA revealed it was a likely pathogenic duplication although previous report showed a reduced penetrance in one family study \[[@CR19]\].

Although we demonstrated that high-resolution CMA played an important role in the identification of pathogenic copy number variants in chromosome 9 pericentric regions, the lack of BAC-FISH analysis as a routine setting in the large reference laboratory renders significant challenges in further characterization of chromosome 9 variants. The major advantage of using CMA as the first-tier test is to detect pathogenic CNVs across the whole genome including chromosome 9. However, when a huge amount of heterochromatin and large tracks of segmentally duplicated euchromatin are present in chromosome 9 pericentric regions, CMA was unable to differentiate tandem, inverted and insertional duplication, or to confirm pericentric inversion. Our cohort supported using CMA as first-tier test when chromosomal disorders were indicated to rule out the presence of pathogenic copy number variants, and using BAC-FISH analysis to further evaluate heterochromatic and euchromatic variants of chromosome 9.
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Additional file 1: Table S1.List of genes that are involved in the CNVs of case 1-3. (DOC 32 kb)Additional file 2: Figure S1.The extra G-positive band was most likely C-positive by C-banding analysis (arrow) in one chromosome 9 homologue, which indicated that the extra band was heterochromatin in origin. The other chromosome 9 homologue also showed a large amount of heterochromatin (arrow head). The C-banding result was not 100 % conclusive, and thus using BAC-FISH with proper probes will be able to confirm this result. (JPG 28 kb)
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